Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
Phoebe FriesenArthur L CaplanJennifer E MillerPublished in: Journal of clinical pharmacy and therapeutics (2019)
Multicentre formulary development, where resources are pooled across institutions, may lead to a reduction in the influence of conflicts of interest in pharmacy and therapeutics committee processes in the United States, increasing the chances of including the most safe, efficacious and cost-effective drugs on formularies.